Search Results - "Cuiffo, Benjamin G."
-
1
MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis
Published in Cell stem cell (04-12-2014)“…Mesenchymal stem/stromal cells (MSCs) are progenitor cells shown to participate in breast tumor stroma formation and to promote metastasis. Despite expanding…”
Get full text
Journal Article -
2
Mesenchymal stem cells in tumor development: Emerging roles and concepts
Published in Cell adhesion & migration (01-05-2012)“…Mesenchymal stem cells (MSCs) are multipotent progenitor cells that participate in the structural and functional maintenance of connective tissues under normal…”
Get full text
Journal Article -
3
GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling
Published in PloS one (26-03-2021)“…Oral mucositis (OM) is a common, painful side effect of radiation therapy used for the treatment of head and neck cancer (HNC). Activation of the innate immune…”
Get full text
Journal Article -
4
Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription
Published in The Journal of biological chemistry (01-03-2002)“…Huntingtin is a protein of unknown function that contains a polyglutamine tract, which is expanded in patients with Huntington's disease (HD). We investigated…”
Get full text
Journal Article -
5
Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell‐Like Phenotypic Traits in Triple‐Negative Breast Cancers
Published in Stem cells (Dayton, Ohio) (01-10-2019)“…The fibrotic tumor microenvironment is a critical player in the pathogenesis of triple‐negative breast cancers (TNBCs), with the presence of fibroblastic…”
Get full text
Journal Article -
6
Lysosomal proteases are involved in generation of N-terminal huntingtin fragments
Published in Neurobiology of disease (01-05-2006)“…N-terminal mutant huntingtin (N-mhtt) fragments form inclusions and cause cell death in vitro. Mutant htt expression stimulates autophagy and increases levels…”
Get full text
Journal Article -
7
Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers
Published in Science signaling (21-02-2017)“…Basal-like breast cancers (BLBCs) exhibit hyperactivation of the phosphoinositide 3-kinase (PI3K) signaling pathway because of the frequent mutational…”
Get more information
Journal Article -
8
Silencing FOXP2 in breast cancer cells promotes cancer stem cell traits and metastasis
Published in Molecular & cellular oncology (03-05-2016)“…In a recent article in Cell Stem Cell, we showed that mesenchymal stem cells (MSCs), progenitor cells that populate the breast tumor stroma, induce…”
Get full text
Journal Article -
9
Abstract 633: Gene-expression characterization of bioluminescent PDX in orthotopic and ectopic models of pancreatic cancer and metastatic triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Background: Patient derived xenografts (PDX) are regarded as the gold-standard for translational preclinical cancer research due to their preservation…”
Get full text
Journal Article -
10
Abstract 585: Colitis in tumor-bearing mice undergoing checkpoint inhibitor therapy
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Checkpoint inhibitor (CPI) therapy represents an exciting new treatment option for patients with advanced malignancies. However, several adverse…”
Get full text
Journal Article -
11
Abstract 1146: Early PD-1 inhibition abrogates PBMC engraftment in a triple-humanized (tumor/PBMC/MSC) bioluminescent orthotopic model of pancreatic cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Accuracy of context is critical in efforts to improve the translational potential of preclinical oncology models. Pancreatic cancer has high mortality…”
Get full text
Journal Article -
12
Abstract 5113: INTASYL self-delivering RNAi therapeutic dual targeting PD-1 and CTLA-4 provides synergistic antitumor efficacy in the treatment of murine colon cancer in vivo
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Combination immune checkpoint inhibition (ICI) with antibodies targeting PD-1 and CTLA-4 provides superior outcomes compared to either monotherapy…”
Get full text
Journal Article -
13
Abstract 1846: Intratumoral mPH-762, a self-delivering RNAi therapeutic (INTASYL™) targeting mouse PD-1, generates systemic tumor-specific memory CD8 T cells, providing a mechanism for abscopal efficacy toward untreated tumors in a murine hepatocarcinoma model
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Intratumoral (IT) administration of immune checkpoint inhibition (ICI) holds potential to enhance local activity while decreasing systemic toxicity,…”
Get full text
Journal Article -
14
Abstract 1499: Recolonizing microbiota may impact tumor response to PD-1 inhibition following antibiotic and radiotherapy treatment in a bioluminescent orthotopic model of murine lung cancer
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Mounting clinical and preclinical evidence demonstrates an important role for the intestinal microbiome in mediating efficacy of immune checkpoint…”
Get full text
Journal Article -
15
Abstract 511: An assessment of pre-conditioning regimens for optimal hCD34+ hematopoietic stem cell humanization of NSGTMmice
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Humanized immune system (HIS) mice - immunocompromised Nod.Cg-Prkdcscid Il2rgtm1Wjl/SzJ animals in which the immune system has been humanized by the…”
Get full text
Journal Article -
16
Abstract 2683: The gastrointestinal microbiome and its composition are critical for antitumor efficacy of immune checkpoint inhibition by anti-PD-L1
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract The intestinal microbiome has become increasingly appreciated as a significant mediator of systemic antitumor immunity/response in both naïve and…”
Get full text
Journal Article -
17
Abstract A9: Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer predict efficacy of standard of care and experimental treatments
Published in Molecular cancer therapeutics (01-12-2015)“…Abstract Background: Only 5% of investigational anti-cancer agents are ultimately clinically successful. This may be attributed in part to the historical…”
Get full text
Journal Article -
18
Palmitoylation of Oncogenic NRAS Is Essential for Leukemogenesis
Published in Blood (16-11-2007)“…Activating mutations of NRAS are found in 20%–40% of acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and myelodysplastic syndrome (MDS)…”
Get full text
Journal Article -
19
Abstract P1-07-02: Mesenchymal stem cell regulated microRNAs converge on the speech gene FOXP2 and regulate breast cancer metastasis
Published in Cancer research (Chicago, Ill.) (01-05-2015)“…Abstract About 90% of breast cancer mortalities are due to the spread of breast cancer cells (BCCs) from a primary tumor to distant organs, a process known as…”
Get full text
Journal Article